Comparative Chemical and Pharmacodynamic Evaluation of Different Purification Procedures for Yangxin Dingji Capsules
Biomedical Chromatography · 2026
DOI: 10.1002/bmc.70641 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Biomedical Chromatography, 2026. Verfasst von Xinyao Lu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Traditional Chinese Medicine Processing Technology Innovation Centre of Hebei Province, College of Pharmacy, Hebei University of Chinese Medicine, Sh…. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Anti-Arrhythmia Agents. Die Arbeit nennt 19 Literaturangaben. Gefördert von: the Hebei Science and Technology Program, the Key R&D plan of Hebei Province, the Key Program of the Joint Fund for Innovation and Development of Traditional Chinese Medicine of the Natural Science Foundation of Hebei Province.
Abstract (Originalsprache)
Yangxin Dingji Capsules (YXDJ), derived from Zhigancao Decoction, are used clinically for arrhythmia. Four D101 macroporous‐resin purification procedures involving different Asini Corii Colla incorporation modes and elution solvents were compared; the co‐decoction procedures additionally included centrifugation and filtration before resin purification. The unpurified preparation and four purified preparations were characterized by UPLC‐Q‐TOF‐MS/MS and evaluated in a barium chloride‐induced rat arrhythmia model using electrocardiographic, biochemical, and histopathological indicators. Fifty‐five constituents were tentatively identified. The 60% ethanol‐eluted preparations CF1 and CF3 retained 52 and 51 constituents, respectively, whereas the water‐eluted preparations CF2 and CF4 retained 21 and 14. CF1 showed the highest Pearson correlation with YXDJ among the purified preparations ( r = 0.520), while CF3 had the highest five‐indicator comprehensive pharmacodynamic score among the purified preparations (CPS5 = 3.540); unpurified YXDJ scored 3.827. Compared with the model group, CF3 significantly increased heart rate, shortened QRS duration, reduced serum lactate dehydrogenase, and increased Na + /K + ‐ATPase activity. Exploratory one‐component partial least‐squares variable‐importance and gray relational analyses generated a provisional list of 12 constituents for subsequent targeted quantification and pharmacological verification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Traditional Chinese Medicine Processing Technology Innovation Centre of Hebei Province, College of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, China.
- Hebei Provincial Technology Innovation Center for Quantitative Research and Application of Traditional Chinese Medicine, Shijiazhuang, China.
- Department of Chinese Materia Medica, Hebei Institute for Drug and Medical Device Control, Shijiazhuang, China.
- Hebei Provincial Classical Formula Chinese Patent Medicine Pharmaceutical Preparation Technology Innovation Center, Hebei Yongfeng Pharmaceutical Co., Ltd., Shijiazhuang, China.
- Traditional Chinese Medicine Hospital of Shijiazhuang City, Shijiazhuang, China.
- School of Agriculture and Medicine, Hebei Open University, Shijiazhuang, China.
Förderung
- the Hebei Science and Technology Program
- the Key R&D plan of Hebei Province
- the Key Program of the Joint Fund for Innovation and Development of Traditional Chinese Medicine of the Natural Science Foundation of Hebei Province
- the Science and Technology Project of National Administration of Traditional Chinese Medicine
- the Scientific Research Project of Hebei Provincial Administ
Zitieren
APA
Lu, X., Li, D., Hou, Z., An, Q., Hou, F., Xue, Z., Xie, Z., Liu, Y., Zheng, Q., Li, Y., Guo, L., & Zhang, D. (2026). Comparative Chemical and Pharmacodynamic Evaluation of Different Purification Procedures for Yangxin Dingji Capsules. Biomedical Chromatography. https://doi.org/10.1002/bmc.70641
Vancouver
Lu X, Li D, Hou Z, An Q, Hou F, Xue Z, et al. Comparative Chemical and Pharmacodynamic Evaluation of Different Purification Procedures for Yangxin Dingji Capsules. Biomedical Chromatography. 2026. doi:10.1002/bmc.70641
BibTeX
@article{Lu2026,
author = {Lu, Xinyao and Li, Datong and Hou, Zitan and An, Qi and Hou, Fangjie and Xue, Zijing and Xie, Zan and Liu, Yongli and Zheng, Qian and Li, Yin and Guo, Long and Zhang, Dan},
title = {Comparative Chemical and Pharmacodynamic Evaluation of Different Purification Procedures for Yangxin Dingji Capsules},
journal = {Biomedical Chromatography},
year = {2026},
doi = {10.1002/bmc.70641}
}
EUVIMED